Autism spectrum disorder in under 19s recognition, referral, and diagnosis : [a] evidence review for factors and neurodevelopmental disorders that increase the likelihood of a diagnosis of autism spectrum disorder
The NICE guideline (CG128) on diagnosing autism spectrum disorders (ASD) was reviewed by the surveillance programme in September 2016. The surveillance process identified new evidence indicating that the current recommendations on factors associated with an increased prevalence of ASD should be upda...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
London
National Institute for Health and Care Excellence
2017, December 2017
|
| Edition: | Final |
| Series: | NICE guideline
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The NICE guideline (CG128) on diagnosing autism spectrum disorders (ASD) was reviewed by the surveillance programme in September 2016. The surveillance process identified new evidence indicating that the current recommendations on factors associated with an increased prevalence of ASD should be updated. The following key factors were identified for consideration: being small for gestational age, prenatal use of selective serotonin reuptake inhibitors (SSRIs), and use of fertility treatments and the presence of neurodevelopmental disorders. This update reviews the evidence for these factors and considers whether they may alter the likelihood that a person has ASD and whether clinicians should take account of these factors when considering referral for an ASD diagnostic assessment |
|---|---|
| Physical Description: | 1 PDF file (108 pages) illustrations |